Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism

Thrombosis Research

Volumn 127, Issue 1, 2011, Pages 39-46

  Owen, B A L ^a,b   Xue, A ^b   Heit, J A ^b   Owen, W G ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Microparticles; Procoagulant phospholipid; Thrombin generation; Venous Thromboembolism (VTE)

Indexed keywords

LIPOSOME; NANOPARTICLE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PROCOAGULANT; THROMBIN;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; BLOOD CLOTTING; CALIBRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; PARTICLE SIZE; PRIORITY JOURNAL; SEX DIFFERENCE; THROMBOCYTE; THROMBOEMBOLISM; VENOUS THROMBOEMBOLISM;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MIDWESTERN UNITED STATES; PHOSPHOLIPIDS; SEX FACTORS; THROMBIN; THROMBOPLASTIN; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 78650510556     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.10.018     Document Type: Article

References (47)

1. K. Karnicki, W.G. Owen, R.S. Miller, and R.D. McBane Factors contributing to an individual propensity for arterial thrombosis Arterioscler Thromb Vasc Biol 22 2002 1495 1499
2. P. Bogaty, N.M. Robitaille, S. Solymoss, L. Boyer, D. Auger, and L. Labbe Atherogenic, hemostatic, and other potential risk markers in subjects with previous isolated myocardial infarction compared with long-standing uncomplicated stable angina Am Heart J 136 1998 884 893
3. P. Bogaty, P. Poirier, S. Simard, L. Boyer, S. Solymoss, and G.R. Dagenais Biological Profiles in Subjects With Recurrent Acute Coronary Events Compared With Subjects With Long-Standing Stable Angina Circulation 103 2001 3062 3068
4. Eichinger S., and Kyrle P.A. Duration of anticoagulation after initial idiopathic venous thrombosis - the swinging pendulum: Risk assessment to predict recurrence J Thromb Haemost 7 Suppl. 1 2009 291 295
5. Baglin T. What happens after venous thromboembolism? J Thromb Haemost 7 Suppl. 1 2009 287 290
6. G. Palareti, and B. Cosmi Bleeding with anticoagulation therapy - who is at risk, and how best to identify such patients Thromb Haemost 102 2009 268 278
7. H. Bounameaux, and A. Perrier Duration of Anticoagulation Therapy for Venous Thromboembolism Hematol Am Soc Hematol Educ Program 2008 252 258
8. C. Kearon Balancing risks and benefits of extended anticoagulant therapy for idiopathic venous thrombosis J Thromb Haemost 7 Suppl. 1 2009 296 300
9. M. Besser, Baglin, C.R. Luddington, A. van Hylckama Vlieg, and T. Baglin High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study J Thromb Haemost 6 2008 1720 1725
10. G. Hron, M. Kollars, B.R. Binder, S. Eichinger, and P.A. Kyrle Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation J Am Med Assoc 296 2006 397 402
11. P.L. Lutsey, A.R. Folsom, S.R. Heckbert, and M. Cushman Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study J Thromb Haemost 7 2009 1639 1648
12. K. Meijer, and S. Schulman The absence of 'minor' risk factors for recurrent venous thromboembolism: a systematic review of negative predictive values and negative likelihood ratios J Thromb Haemost 7 2009 1619 1628
13. S. Eichinger, G. Hron, M. Kollars, and P.A. Kyrle Prediction of Recurrent Venous Thromboembolism by Endogenous Thrombin Potential and D-Dimer Clin Chem 54 2008 2042 2048
14. T. Zhu, I. Martinez, and J. Emmerich Venous Thromboembolism: Risk Factors for Recurrence Arterioscler Thromb Vasc Biol 29 2009 298 310
15. S. McRae, H. Tran, S. Schulman, J. Ginsberg, and C. Kearon Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis Lancet 368 2006 371 378
16. P.A. Kyrle, E. Minar, C. Bialonczyk, M. Hirschl, A. Weltermann, and S. Eichinger The Risk of Recurrent Venous Thromboembolism in Men and Women N Engl J Med 350 2004 2558 2563
17. R.H. White, and C.R. Keenan Effects of race and ethnicity on the incidence of venous thromboembolism Thromb Res 123 Suppl. 4 2009 S11 S17
18. P. van Dreden Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction Blood Coagul Fibrinolysis 20 2009 635 641
19. P. van Dreden Clinical evaluation of a new functional test for detection of plasma procoagulant phospholipids Blood Coagul Fibrinolysis 20 2009 494 502
20. P.G. Barton, E.T. Yin, and S. Wessler Reactions of activated factor X-phosphatide mixtures in vitro and in vivo J Lipid Res 11 1970 87 95
21. O. Morel, N. Morel, J.-M. Freyssinet, and F. Toti Platelet microvesicles and vascular cells interactions: A checkpoint between the haemostatic and thrombotic responses Platelets 19 2008 9 23
22. G. Piazza, and S.Z. Goldhaber Venous Thromboembolism and Atherothrombosis An Integrated Approach Circulation 121 2010 2146 2150
23. X. Wang, M.-Y. Hsu, T.E. Steinbacher, T.M. Monticello, and W.A. Schumacher Quantification of platelet composition in experimental venous thrombosis by real-time polymerase chain reaction Thromb Res 119 2007 593 600
24. S. Ederhy, E. Di Angelantonio, Z. Mallat, B. Hugel, S. Janower, and C. Meuleman Levels of Circulating Procoagulant Microparticles in Nonvalvular Atrial Fibrillation Am J Cardiol 100 2007 989 994
25. H.C. Hemker, R. Al Dieri, and S. Béguin Thrombin generation assays: accruing clinical relevance Curr Opin Hematol 11 2004 170 175
26. H.C. Hemker, P. Giesen, R. Al Dieri, V. Regnault, E. de Smedt, and R. Wagenvoord Calibrated automated thrombin generation measurement in clotting plasma Pathophysiol Haemost Thromb 33 2003 4 15
27. H.C. Hemker, P.L.A. Giesen, M. Ramjee, R. Wagenvoord, and S. Béguin The Thrombogram: Monitoring Thrombin Generation in Platelet Rich Plasma Thromb Haemost 83 2000 589 591
28. S.N. Gitel, W.G. Owen, C.T. Esmon, and C.M. Jackson A Polypeptide Region of Bovine Prothrombin Specific for Binding to Phospholipids Proc Natl Acad Sci USA 70 1973 1344 1348
29. M. Jayachandran, R.D. Litwiller, W.G. Owen, J.A. Heit, T. Behrenbeck, and S.L. Mulvagh Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women Am J Physiol Heart Circ Physiol 295 2008 H931 H938
30. D.E. Connor, T. Exner, D.D.F. Ma, and J.E. Joseph Detection of the procoagulant activity of microvesicle associated phosphatidylserine using XACT Blood Coagul Fibrinolysis 20 2009 558 564
31. D.T.S. Rijkers, S.J.H. Wielders, S. Béguin, and H.C. Hemker Prevention of the Influence of Fibrin and α2-Macroglobulin in the Continuous Measurement of the Thrombin Potential: Implications for an Endpoint Determination of the Optical Density Thromb Res 89 1998 161 169
32. W.L. Chandler, and M. Roshal Optimization of Plasma Fluorogenic Thrombin-Generation Assays Am J Clin Pathol 132 2009 169 179
33. K. Varadi, P.L. Turecek, and H.P. Schwarz Thrombin generation assay and other universal tests for monitoring haemophilia therapy Haemophilia 10 Suppl. 2 2004 17 21
34. O. Morel, F. Toti, N. Morel, and J.M. Freyssinet Microparticles in endothelial cell and vascular homeostasis: are they really noxious? Haematologica 94 2009 313 317
35. H.C. Hemker, P. Giesen, R. Al Dieri, V. Regnault, E. de Smed, and R. Wagenvoord The Calibrated Automated Thrombogram (CAT): a universal routine test for hyper and hypocoagulability Pathophysiol Haemost Thromb 32 2002 249 253
36. G.T. Gerotziafas, F. Depasse, J. Busson, L. Leflem, I. Elalamy, and M.M. Samama Towards a standardization of thrombin generation assessment: The influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay Thromb J 3 2005 16
37. A. Tripodi, C. Legnani, V. Chantarangkul, B. Cosmi, G. Palareti, and P.M. Mannucci High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism J Thromb Haemost 6 2008 1327 1333
38. F. Dignat-George, J.-M. Freyssinet, and N.S. Key Centrifugation is a crucial step impacting microparticle measurement Platelets 20 2009 225 226
39. K. Devreese, K. Peerlinck, J. Arnout, and M.F. Hoylaerts Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography Thromb Haemost 101 2009 185 196
40. K. Devreese, K. Peerlinck, and M.F. Hoylaerts Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants Blood 115 2010 870 878
41. C. Ay, J.-M. Freyssinet, T. Sailer, R. Vormittag, and I. Pabinger Circulating procoagulant microparticles in patients with venous thromboembolism Thromb Res 123 2009 724 726
42. S.K. Dasgupta, P. Guchhait, and P. Thiagarajan Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5 Transl Res 148 2006 19 25
43. J. Shi, S.W. Pipe, J.T. Rasmussen, C.W. Heegard, and G.E. Gilbert Lactadherin blocks thrombosis and hemostasis in vivo: correlation with platelet phosphatidylserine exposure J Thromb Haemost 6 2008 1167 1174
44. A.-M. Albanyan, M.F. Murphy, J.T. Rasmussen, C.W. Heegaard, and P. Harrison Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V Transfusion 49 2009 99 107
45. L. Eischer, S. Eichinger, and P.A. Kyrle Age at First Venous Thromboembolism and Risk of Recurrence: A Prospective Cohort Study Medicine 88 2009 366 370
46. P. Bucciarelli, and P.M. Mannucci The hemostatic system through aging and menopause Climateric 12 S1 2009 47 51
47. D. Mari, P.M. Mannucci, R. Coppola, B. Bottasso, K.A. Bauer, and R.D. Rosenberg Hypercoagulability in Centenarians: The Paradox of Successful Aging Blood 85 1995 3144 3149